When to cryopreserve ovarian tissue: Determining the effects of chemotherapy on the ovarian reserve by studying follicular density and apoptosis.


Journal

Cytopathology : official journal of the British Society for Clinical Cytology
ISSN: 1365-2303
Titre abrégé: Cytopathology
Pays: England
ID NLM: 9010345

Informations de publication

Date de publication:
03 2023
Historique:
received: 08 11 2022
accepted: 25 11 2022
pubmed: 3 12 2022
medline: 8 2 2023
entrez: 2 12 2022
Statut: ppublish

Résumé

Patients scheduled to receive chemotherapy should be counselled on fertility preservation. Known gonadotoxic chemotherapies such as alkylating agents have a high risk of altering ovarian reserve. In some cases, the urgency of treatment requires the use of chemotherapy before fertility preservation, which will be carried out at a later stage. Usually the ovarian tissue is cryopreserved. The aim of our study is to investigate the impact of chemotherapies on follicular density and the apoptosis of reserve follicles. We included 140 patients: 63 patients, mean age 18.8 years, were included in the group "no chemotherapy" (group A) and 77 patients, mean age 17.1 years, in the group "received chemotherapy before ovarian conservation" (group B). None of the patients had had pelvic radiotherapy prior to ovarian cryopreservation. The histological parameters studied were follicular density and the presence of malignant cells. We selected 12 patients from group A and 15 patients from group B, comparable in age and pathology, for whom we evaluated follicle apoptosis by immunostaining cleaved caspase-3. We demonstrated an inverse relationship between follicular density and age (p < 0.0001), as well as a lack of effect of chemotherapy on follicular density (p = 0.87). We showed the impact of various chemotherapies, especially with alkylating agents, on the apoptosis of ovarian follicles (p < 0.0001). Three patients had ovarian tissue infiltration, two of which were malignant. This work underlines the fact that conservation of ovarian tissue after chemotherapy remains possible.

Identifiants

pubmed: 36458472
doi: 10.1111/cyt.13194
pmc: PMC10107618
doi:

Substances chimiques

Alkylating Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-153

Informations de copyright

© 2022 The Authors. Cytopathology published by John Wiley & Sons Ltd.

Références

Cancer. 1990 Nov 15;66(10):2099-104
pubmed: 2224764
Hum Reprod. 2014 Jan;29(1):107-13
pubmed: 24221908
Aging (Albany NY). 2011 Aug;3(8):782-93
pubmed: 21869459
Hum Reprod. 2015 Mar;30(3):608-15
pubmed: 25567618
N Engl J Med. 2018 Jan 25;378(4):400-401
pubmed: 29365297
Fertil Steril. 2020 Aug;114(2):279-280
pubmed: 32741467
Hum Reprod. 2010 Jul;25(7):1708-12
pubmed: 20472912
J Clin Oncol. 2006 Jun 20;24(18):2917-31
pubmed: 16651642
Fertil Steril. 2011 Feb;95(2):803.e3-6
pubmed: 20801440
Br J Cancer. 2006 Apr 10;94(7):1007-10
pubmed: 16570049
Fertil Steril. 2013 May;99(6):1514-22
pubmed: 23541406
Hum Reprod. 1993 Dec;8(12):2080-7
pubmed: 8150906
Cytopathology. 2023 Mar;34(2):146-153
pubmed: 36458472
J Endocrinol. 2019 Feb 1;240(2):243-256
pubmed: 30530902
Hum Reprod. 2008 Apr;23(4):869-77
pubmed: 18263640
Hum Reprod. 2007 Jun;22(6):1626-33
pubmed: 17324957
Blood. 2010 Oct 21;116(16):2908-14
pubmed: 20595517
Fertil Steril. 2001 Apr;75(4):754-62
pubmed: 11287031
Cancer. 2007 Nov 15;110(10):2222-9
pubmed: 17932880
Br J Cancer. 1978 Jul;38(1):82-7
pubmed: 687521
J Assist Reprod Genet. 2013 Mar;30(3):305-14
pubmed: 23417329
Obstet Gynecol Int. 2012;2012:910698
pubmed: 22518166
J Oncol Pract. 2018 Jun;14(6):381-385
pubmed: 29768110
Fertil Steril. 2010 Nov;94(6):2186-90
pubmed: 20100619
Fertil Steril. 2020 Aug;114(2):388-397
pubmed: 32605799
Hum Reprod. 2002 Jun;17(6):1447-52
pubmed: 12042259
Hum Reprod Update. 2013 Sep-Oct;19(5):483-506
pubmed: 23817363
Fertil Steril. 2021 May;115(5):1239-1249
pubmed: 33485607
Reprod Sci. 2020 Apr;27(4):955-962
pubmed: 32046442

Auteurs

Elsa Labrune (E)

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.
Université Claude Bernard, Faculté de Médecine Laennec, Lyon Cedex 08, France.
INSERM Unité 1208, Bron Cedex, France.

Serge Bianchetti (S)

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.
Université Claude Bernard, Faculté de Médecine Laennec, Lyon Cedex 08, France.
INSERM Unité 1208, Bron Cedex, France.

Odile Lepinasse (O)

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.
INSERM Unité 1208, Bron Cedex, France.

Gaelle Soignon (G)

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.

Bruno Salle (B)

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.
INSERM Unité 1208, Bron Cedex, France.
Université Claude Bernard, Faculté de Médecine Lyon Sud, Oullins Cedex, France.

Jacqueline Lornage (J)

Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.
INSERM Unité 1208, Bron Cedex, France.
Université Claude Bernard, Faculté de Médecine Lyon Sud, Oullins Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH